EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Natural Agents as Novel Potential Source of Proteasome Inhibitors with Anti-Tumor Activity: Focus on Multiple Myeloma

Francesca Alessandra Ambrosio iD, Giosuè Costa iD, Maria Eugenia Gallo Cantafio, Roberta Torcasio, Francesco Trapasso, Stefano Alcaro, Giuseppe Viglietto, Nicola Amodio

Molecules · 02.02.2023 · 28 (3) · 1438

DOI: 10.3390/molecules28031438 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 02.02.2023. Verfasst von Francesca Alessandra Ambrosio und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, Campus "S. Venuta", University "Magna Græcia" of Catanzaro, Viale Europa, 88100 Catanzaro, Italy. Hauptthemen laut MEDLINE: Multiple Myeloma, Antineoplastic Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, Italian Ministry of Health, Ministry of Education, Universities and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is an aggressive and incurable disease for most patients, characterized by periods of treatment, remission and relapse. The introduction of new classes of drugs, such as proteasome inhibitors (PIs), has improved survival outcomes in these patient populations. The proteasome is the core of the ubiquitin–proteasome system (UPS), a complex and conserved pathway involved in the control of multiple cellular processes, including cell cycle control, transcription, DNA damage repair, protein quality control and antigen presentation. To date, PIs represent the gold standard for the treatment of MM. Bortezomib was the first PI approved by the FDA, followed by next generation of PIs, namely carfilzomib and ixazomib. Natural agents play an important role in anti-tumor drug discovery, and many of them have recently been reported to inhibit the proteasome, thus representing a new potential source of anti-MM drugs. Based on the pivotal biological role of the proteasome and on PIs’ significance in the management of MM, in this review we aim to briefly summarize recent evidence on natural compounds capable of inhibiting the proteasome, thus triggering anti-MM activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaAntineoplastic AgentsHumansProteasome InhibitorsProteasome Endopeptidase ComplexBortezomib

Stichwörter der Autor:innen

multiple myelomanatural compoundsproteasomeproteasome inhibitors

Substanzen

Proteasome InhibitorsProteasome Endopeptidase ComplexAntineoplastic AgentsBortezomib

Autor:innen und Institutionen

  • Department of Experimental and Clinical Medicine, Campus "S. Venuta", University "Magna Græcia" of Catanzaro, Viale Europa, 88100 Catanzaro, Italy.
  • Department of Health Sciences, University "Magna Græcia" of Catanzaro, Campus "S. Venuta", Viale Europa, 88100 Catanzaro, Italy.
  • Net4Science Academic Spin-Off, University "Magna Græcia" of Catanzaro, Campus "S. Venuta", Viale Europa, 88100 Catanzaro, Italy.
  • Department of Biology, Ecology and Earth Sciences (Di.B.E.S.T.), University of Calabria, 87036 Rende, Italy.
  • Associazione CRISEA-Centro di Ricerca e Servizi Avanzati per l'Innovazione Rurale, Loc. Condoleo, 88055 Belcastro, Italy.

ORCID-Profile: Francesca Alessandra Ambrosio, Giosuè Costa

Förderung

  • Italian Association for Cancer Research
  • Italian Ministry of Health
  • Ministry of Education, Universities and Research
  • PRIN 2017 research project

Zitieren

APA

Ambrosio, F. A., Costa, G., Gallo Cantafio, M. E., Torcasio, R., Trapasso, F., Alcaro, S., Viglietto, G., & Amodio, N. (2023). Natural Agents as Novel Potential Source of Proteasome Inhibitors with Anti-Tumor Activity: Focus on Multiple Myeloma. Molecules, 28(3), 1438. https://doi.org/10.3390/molecules28031438

Vancouver

Ambrosio FA, Costa G, Gallo Cantafio ME, Torcasio R, Trapasso F, Alcaro S, et al. Natural Agents as Novel Potential Source of Proteasome Inhibitors with Anti-Tumor Activity: Focus on Multiple Myeloma. Molecules. 2023;28(3):1438. doi:10.3390/molecules28031438

BibTeX
@article{Ambrosio2023,
  author = {Ambrosio, Francesca Alessandra and Costa, Giosuè and Gallo Cantafio, Maria Eugenia and Torcasio, Roberta and Trapasso, Francesco and Alcaro, Stefano and Viglietto, Giuseppe and Amodio, Nicola},
  title = {Natural Agents as Novel Potential Source of Proteasome Inhibitors with Anti-Tumor Activity: Focus on Multiple Myeloma},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {3},
  pages = {1438},
  doi = {10.3390/molecules28031438}
}
Kostenlos starten →